Molecular form of immunoreactive endothelin in plasma and urine of normal subjects and patients with various disease states.
To elucidate the pathophysiologic significance of the family of endothelin (ET) peptides, we have investigated plasma and urinary immunoreactive (ir-) ET levels and its molecular forms in normal and pathological conditions. Plasma and urine ET were extracted with an Amprep C2 column. The molecular form of ET was determined by a combination of radioimmunoassay and reverse-phase high-performance liquid chromatography. Although plasma ir-ET was composed mainly of big ET and endothelin-1 (ET-1) in normal subjects, that in acute myocardial infarction, chronic renal failure (CRF), essential hypertension, and vasospastic angina pectoris was characterized by an increase of high molecular ir-ET in addition to increases in big ET and ET-1. Urinary ir-ET in both normal subjects and patients with CRF was composed mainly of a high molecular form in addition to big ET and ET-1. These results suggest that the biosynthetic and/or degradation process of ET under pathological conditions appears to be different from that under normal conditions.
Naruse
K
K
Department of Medicine, Tokyo Women's Medical College, Japan.
Naruse
M
M
Watanabe
Y
Y
Yoshihara
I
I
Ohsumi
K
K
Horiuchi
J
J
Monzen
C
C
Kato
Y
Y
Nakamura
N
N
Sugino
N
N
D000787:Angina Pectoris / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000378:metabolism*; D019332:Endothelin-1; D016232:Endothelins / Q000097:blood / Q000737:chemistry* / Q000652:urine; D006801:Humans; D006973:Hypertension / Q000378:metabolism; D007674:Kidney Diseases / Q000378:metabolism*; D009203:Myocardial Infarction / Q000378:metabolism; D011498:Protein Precursors / Q000737:chemistry
D019332:Endothelin-1; D016232:Endothelins; D011498:Protein Precursors